Page last updated: 2024-12-07

5,5'-dimethyl-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5,5'-dimethyl-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetate: calcium chelator; do not confuse with calcium specific chelator (MAPTAM buffer) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

5,5'-dimethyl-BAPTA : A polyamino carboxylic acid, the structure of which is that of BAPTA carrying methyl substituents at C-5 and C-5'. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID123719
CHEBI ID60889
SCHEMBL ID16003057
MeSH IDM0162389

Synonyms (18)

Synonym
dimethyl bis-(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid
n,n'-(1,2-ethanediylbis(oxy(4-methyl-2,1-phenylene)))bis(n-(carboxymethyl))glycine
CHEBI:60889
5,5'-dimethyl-bapta
(ch3)2-bapta
2,2',2'',2'''-{ethane-1,2-diylbis[oxy(4-methyl-2,1-phenylene)nitrilo]}tetraacetic acid
bis(2-amino-5-methylphenoxy)ethane-n,n,n',n'-tetraacetate
5,5'-dimethyl-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetate
91416-19-2
unii-78h4va776p
me2bapta
78h4va776p ,
glycine, n,n'-(1,2-ethanediylbis(oxy(4-methyl-2,1-phenylene)))bis(n-(carboxymethyl)-
SCHEMBL16003057
DTXSID10238554
Q27129463
n,n'-(1,2-ethanediylbis(oxy(4-methyl-2,1-phenylene)))bis(n-(carboxymethyl)glycine)
2,2',2'',2'''-(1,2-ethanediylbis(oxy(4-methyl-2,1-phenylene)nitrilo))tetraaceticacid

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Both responses were dependent on the concentration of thrombin, displaying a sigmoidal dose-response pattern."( Intracellular calcium mobilization and activation of the Na+/H+ exchanger in platelets.
Botey, A; Cases, A; Gaya, J; Poch, E; Revert, L; Rivera, F, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
chelatorA ligand with two or more separate binding sites that can bind to a single metallic central atom, forming a chelate.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
polyamino carboxylic acidAn amino acid containing one or more nitrogen atoms connected through carbon atoms to one or more carboxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (45)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (8.89)18.7374
1990's30 (66.67)18.2507
2000's8 (17.78)29.6817
2010's3 (6.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.24 (24.57)
Research Supply Index3.85 (2.92)
Research Growth Index5.09 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other46 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]